101869-74-3

Basic information

• Product Name: Cyclohexanemethanol, 4-methoxy-
• CAS NO: 101869-74-3
• Molecular Formula: C8H16O2
• Molecular Weight: 144.214
• Mol File: 101869-74-3.mol
• Article Data: 15

Chemical Properties

• CAS DataBase Reference: Cyclohexanemethanol, 4-methoxy-(CAS DataBase Reference)
• NIST Chemistry Reference: Cyclohexanemethanol, 4-methoxy-(101869-74-3)
• EPA Substance Registry System: Cyclohexanemethanol, 4-methoxy-(101869-74-3)

Safety Data

• Hazardous Substances Data: 101869-74-3(Hazardous Substances Data)

Upstream product

• 223677-02-9 ethyl 4-methoxycyclohexanecarboxylate 
• 123-11-5 4-methoxy-benzaldehyde 
• 3618-04-0 4-hydroxycyclohexyl carboxylic acid ethyl ester 
• 99-96-7 4-hydroxy-benzoic acid 
• 3685-26-5 trans-4-hydroxycyclohexanecarboxylic acid 
• 3618-04-0 trans-4-hydroxy-cyclohexane carboxylic acid ethyl ester 
• 73873-61-7 trans-4-methoxycyclohexane-1-carboxylic acid 
• 63389-93-5 trans-ethyl 4-methoxycyclohexane-1-carboxylate 
• 73873-62-8 methyl trans-4-methoxycyclohexanecarboxylate 
• 3618-03-9 trans-4-hydroxycyclohexane-1-carboxylic acid methyl ester 
• 67-56-1 methanol 
• 72581-32-9 cyclohex-3-enylmethanol 
• 106434-94-0 1-Methoxy-4-methylencyclohexan 
• 137058-17-4 Methyl cis/trans-4-methoxycyclohexanecarboxylate 

Downstream Products

• 1067230-23-2 C₁₅H₂₂O₄S 
• 1067230-22-1 C₁₅H₂₂O₄S 
• 120552-57-0 (1r,4r)-4-methoxycyclohexane-1-carbaldehyde 
• 120552-57-0 (1s,4s)-4-methoxycyclohexanecarbaldehyde 
• 1332627-43-6 C₁₁H₂₄O₂Si 
• 141604-43-5 2-tert-butyl-4-chloro-5-(4-methoxycyclohexyl)-methylthio-3(2H)-pyridazinone 
• 141604-51-5 (4-methoxy-cyclohexyl)methyl bromide 
• 120552-57-0 4-methoxycyclohexane-1-carbaldehyde 

Relevant articles and documents

SSAO INHIBITORS AND USE THEREOF

Provided are a compound of formula (I') or (I), a pharmaceutically acceptable salt, hydrate, solvate, prodrug, stereoisomer, or tautomer thereof, which modulates the activity of SSAO, a pharmaceutical composition comprising a compound of formula (I') or (I), and a method of treating or preventing a disease in which SSAO plays a role.

3-(5-HYDROXY-1-OXOISOINDOLIN-2-YL)PIPERIDINE-2,6-DIONE DERIVATIVES AND USES THEREOF

The present disclosure provides a compound of Formula (I′): or a pharmaceutically acceptable salt, hydrate, solvate, prodrug, stereoisomer, or tautomer thereof, wherein Rx, X1, X2, and R1 are as defined herein, and methods of making and using same.

Solid dispersions containing an apoptosis-inducing agent

A pro-apoptotic solid dispersion comprises, in essentially non-crystalline form, a Bcl-2 family protein inhibitory compound of Formula I as defined herein, dispersed in a solid matrix that comprises (a) a pharmaceutically acceptable water-soluble polymeric carrier and (b) a pharmaceutically acceptable surfactant. A process for preparing such a solid dispersion comprises dissolving the compound, the polymeric carrier and the surfactant in a suitable solvent, and removing the solvent to provide a solid matrix comprising the polymeric carrier and the surfactant and having the compound dispersed in essentially non-crystalline form therein. The solid dispersion is suitable for oral administration to a subject in need thereof for treatment of a disease characterized by overexpression of one or more anti-apoptotic Bcl-2 family proteins, for example cancer.